Comparative effects of statin and fibrate on nitric oxide bioactivity and matrix metalloproteinase in hyperlipidemia

This publication has 33 references indexed in Scilit:

• Suppression of the Functionally Coupled Cyclooxygenase-2/Prostaglandin E Synthase as a Basis of Simvastatin-Dependent Plaque Stabilization in Humans
  Circulation, 2003
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
  Published by Elsevier ,2002
• Pravastatin Treatment Increases Collagen Content and Decreases Lipid Content, Inflammation, Metalloproteinases, and Cell Death in Human Carotid Plaques
  Circulation, 2001
• Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol
  New England Journal of Medicine, 1999
• Lipid Lowering by Diet Reduces Matrix Metalloproteinase Activity and Increases Collagen Content of Rabbit Atheroma
  Circulation, 1998
• Effect of Gemfibrozil ± Niacin ± Cholestyramine on Endothelial Function in Patients With Serum Low-Density Lipoprotein Cholesterol Levels <160 mg/dl and High-Density Lipoprotein Cholesterol Levels <40 mg/dl
  The American Journal of Cardiology, 1997
• Effects of Hormone-Replacement Therapy on Fibrinolysis in Postmenopausal Women
  New England Journal of Medicine, 1997
• Exercise-induced vasomotion of angiographically normal and stenotic coronary arteries improves after cholesterol-lowering drug therapy with bezafibrate
  Journal of the American College of Cardiology, 1995
• Infiltrates of Activated Mast Cells at the Site of Coronary Atheromatous Erosion or Rupture in Myocardial Infarction
  Circulation, 1995
• Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.
  Journal of Clinical Investigation, 1994